FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Klobuchar Targets Improper Patent Listings

Senator Amy Klobuchar (D-MN) sends letters to six pharmaceutical companies Abbvie, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Mylan-Viatris,...

latest-news-card-1
Human Drugs

FDA OKs Janssens Balversa

FDA approves a Janssen Biotech NDA for Balversa (erdafitinib) for treating certain adult patients with locally advanced or metastatic urothelial carci...

latest-news-card-1
Human Drugs

Alvotech Reinspection Lands 1 Observation

An FDA reinspection of Alvotechs Iceland manufacturing facility results in a Form FDA-483 with one inspection finding.

latest-news-card-1
Human Drugs

Lilly Inspection Cites 8 Findings: Report

A 7/2023 inspection of Eli Lillys Branchburg, NJ cites eight GMP deficiencies, according to inspection documents referenced in a Reuters report.

latest-news-card-1
Federal Register

Panel to Vote on Lumicell NDA

Federal Register notice: FDA announces a 3/5 Medical Imaging Drugs Advisory Committee meeting to review and discuss a Lumicell NDA for pegulicianine f...

latest-news-card-1
Medical Devices

MRI Labeling for Abbott Neurostimulator

FDA approves MRI labeling on Abbotts dorsal root ganglion (DRG) stimulation therapy, the Proclaim DRG neurostimulation system.

latest-news-card-1
Human Drugs

Novocure PMA Filed for Lung Cancer

FDA accepts for review a Novocure PMA that seeks approval for the use of tumor treating fields therapy together with standard systemic therapies for t...

latest-news-card-1
Medical Devices

FDA, CMS Reiterate Need for FDA Test Oversight

FDA and CMS officials call for support of an FDA proposal to regulate laboratory-developed tests.

latest-news-card-1
Federal Register

IRB Waiver Info Collection Approved

Federal Register notice: OMB approves an information collection entitled Institutional Review Board Waiver or Alteration of Informed Consent for Minim...

latest-news-card-1

SCOTUS May Tighten Chevron Deference: Attorneys

Two Axinn attorneys say there will be a flood of cases challenging federal agency decisions and interpretations of law if the Supreme Court restricts ...